Chorangiosis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Chorangiosis
High magnification micrograph of chorangiosis.
Synonyms
Pronounce	N/A
Specialty	N/A
Symptoms	Increased number of chorionic villi capillaries
Complications
Onset
Duration
Types
Causes	Hypoxia, maternal diabetes, high altitude
Risks
Diagnosis	Histopathology
Differential diagnosis
Prevention
Treatment
Medication
Prognosis
Frequency
Deaths

Chorangiosis - intermed mag

Chorangiosis - very high mag

Chorangiosis is a pathological condition affecting the placenta, characterized by an abnormal increase in the number of blood vessels within the chorionic villi, the structures responsible for facilitating nutrient and gas exchange between the mother and fetus. This condition is typically diagnosed through microscopic examination of the placenta after delivery. The diagnosis criteria for chorangiosis include the presence of ten or more capillaries in ten or more villi in ten or more fields at √ó10 magnification. It is considered a sign of chronic hypoxia in the fetus, as the increase in capillary number is thought to be a compensatory mechanism to improve oxygen and nutrient transfer in response to suboptimal conditions.

Etiology

Chorangiosis is associated with several maternal, fetal, and placental conditions that can lead to compromised oxygen delivery to the fetus. These include, but are not limited to, maternal anemia, maternal diabetes, living at high altitudes, and intrauterine growth restriction (IUGR). The exact mechanism leading to chorangiosis is not fully understood, but it is believed to be a response to chronic hypoxic conditions, prompting angiogenesis within the chorionic villi.

Pathophysiology

The pathophysiology of chorangiosis revolves around the body's response to chronic hypoxia. In an attempt to increase the efficiency of oxygen and nutrient transfer from the mother to the fetus, the placenta forms additional blood vessels within the chorionic villi. While this may temporarily alleviate the effects of hypoxia, the presence of chorangiosis can also indicate underlying pathological conditions that may have adverse effects on both the mother and fetus.

Clinical Significance

Chorangiosis itself is typically asymptomatic and is usually diagnosed postpartum through histological examination of the placenta. However, its presence can be indicative of underlying conditions that may require medical attention. It has been associated with an increased risk of neonatal complications, including respiratory distress syndrome and neonatal jaundice. Additionally, chorangiosis may be associated with adverse pregnancy outcomes such as preterm delivery and low birth weight.

Diagnosis

The diagnosis of chorangiosis is made postpartum by examining the placenta under a microscope. The criteria for diagnosis include the presence of an increased number of capillaries in the chorionic villi, specifically ten or more capillaries in ten or more villi in ten or more fields at √ó10 magnification. This examination is typically performed by a pathologist.

Management

Management of chorangiosis involves addressing the underlying conditions that may have led to its development. This can include managing maternal conditions such as diabetes or anemia, monitoring fetal growth and well-being, and making decisions regarding the timing of delivery based on the overall clinical picture. There is no direct treatment for chorangiosis itself, as it is a histopathological diagnosis with no direct clinical interventions.

Summary

Chorangiosis is a placental condition indicative of chronic fetal hypoxia, with potential implications for both maternal and fetal health. While it does not have direct treatments, its identification can prompt closer monitoring and management of underlying conditions that may pose risks to the pregnancy. Understanding the etiology and pathophysiology of chorangiosis is crucial for healthcare providers in optimizing outcomes for affected pregnancies.